BENTSUR RON (Chairman & CEO) received a stock award from NUVECTIS PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/3/2025ACC: 0001104659-25-000909
DirectorOfficer· Chairman & CEO
Since Feb 2022
+250K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
250K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+250K
Price / share
—
Trade value
—
% of position
7.6%
1/2/2025
3.27M→3.52M
Total
Net shares
+250K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2025 | A · Award | +250K | — | — | 7.6% | 3.27M | 3.52M |
| Total | +250K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported